Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients

Soluble receptor activator of nuclear factor κ B ligand (sRANKL) is a member of the tumor necrosis factor receptor superfamily, and therefore, involved in various inflammatory processes. The role of sRANKL in the course of bone remodeling via activation of osteoclasts as well as chronic disease prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Puengel, Tobias, Weber, Beate, Wirtz, Theresa H., Buendgens, Lukas, Loosen, Sven H., Geisler, Lukas, Özdirik, Burcin, Karim, Hamesch, Jhaisha, Samira Abu, Brozat, Jonathan F., Hohlstein, Philipp, Eisert, Albrecht, Yagmur, Eray, Trautwein, Christian, Tacke, Frank, Koch, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774641/
https://www.ncbi.nlm.nih.gov/pubmed/35054232
http://dx.doi.org/10.3390/diagnostics12010062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774641/
https://www.ncbi.nlm.nih.gov/pubmed/35054232
http://dx.doi.org/10.3390/diagnostics12010062

Ejemplares similares